Most active UK investors: angels, VC firms and corporate venture capital
A monthly ranking based on Startupmag's tracking of active UK angel and venture capital investment.
May 2026’s most active investors ranking reflects where UK capital was actually deployed in April 2026, spanning pre-seed, seed and growth rounds across angel investors, venture capital firms and corporate investment arms.
The analysis is based on Startupmag’s investor database, tracking live investment activity across thousands of UK angel investors, venture capital firms and strategic corporate investors.
Across angels, venture capital and corporate backers the month revealed a sector-led, stage-aware market. Fintech, greentech and healthtech dominated overall activity, while deep tech and AI-enabled edtech formed a secondary but highly visible pipeline as capital moved from early validation into commercialisation. Angels concentrated on pre-seed and seed rounds, using operator expertise and signalling power to support fintech and health propositions. Venture firms formed the middle scaling layer, converting research, product traction and specialist technologies into commercial growth rounds. Corporate investors skewed in the opposite direction, committing larger strategic cheques into industrial greentech, battery supply chains and deployment-stage infrastructure where strategic alignment and manufacturing scale matter most.
The pipeline showed particularly strong activity in finance automation, payments infrastructure, battery recycling, industrial climate technologies and health-led software, alongside steady dealflow in quantum, AI-enabled learning and specialist B2B platforms. Specialist regional programmes, mission-led seed funds and co-investment structures continued to widen the early-stage funnel, while industrial corporates concentrated capital into companies with clear technical defensibility, operational relevance and near-term commercial deployment pathways.
- Angels clustered at pre-seed and seed, typically within the £500k to £3m band, providing early validation, operator expertise and signalling power across fintech and healthtech.
- VC firms formed the middle commercialisation layer, deploying capital from structured pre-seed and seed rounds through £3m to £15m growth allocations across deep tech, fintech, edtech and regional scale-ups.
- Corporate and industrial investors concentrated on strategic sectors such as battery infrastructure, greentech and industrial deployment, supplying larger capital alongside manufacturing and operational integration pathways.
These dynamics point to a pragmatic and increasingly integrated UK funding environment. Early experimentation remains active, particularly around fintech infrastructure, applied AI and technical industrial innovation, but capital is flowing most efficiently toward ventures demonstrating clear commercialisation routes, technical depth and strategic scalability. Rather than chasing speculative early-stage glamour, April’s capital was deployed to de-risk technologies and build a functioning pipeline from nascent innovation through to commercial deployment.
Angel investors: fintech-led seed and pre-seed support across £1.8m–$60m rounds
| Angel Investors | April Investments | Investment Focus | Location | Connect |
|---|---|---|---|---|
Matt Clifford Matt Clifford is the Prime Minister's Adviser on AI Opportunities and co-founder of Entrepreneu... | Rivan (£25,000,000, Greentech) |  London | ||
Alan Morgan Alan Morgan is the Chairman and Owner at AdFisco. He is also an angel investor known for his in... | Ralio (£1,800,000, Fintech) | London | ||
Paul Forster Paul Forster is an investor known for his investments in Purple Dot Technologies and Stackfix. ... | Round (£4,500,000, Fintech) | Cambridge | ||
Sir Ronald Cohen Sir Ronald Cohen is widely regarded as one of the founding figures of the UK angel and venture ... | MillTech ($60,000,000, Fintech) | UK | ||
Timo Boldt Timo Boldt is a prominent UK startup founder and active angel investor best known for building ... | Calibre (£2,400,000, Healthtech) | UK |
Matt Clifford, Alan Morgan, Timo Boldt, Paul Forster and Sir Ronald Cohen were the most visible angels in April’s dataset. Fintech was the dominant theme, but there was notable backing of greentech and healthtech. Clifford and Cohen stand out as high-profile, public-facing figures — Clifford as a founder and adviser in AI policy and Cohen as a veteran of British venture capital — while Boldt reads as an operator angel with consumer and healthtech credentials. Morgan and Forster skew fintech and B2B software, reinforcing a cluster around payments, treasury and finance automation. Together these patterns suggest UK angels remain active across stages, concentrating expertise and capital in fintech while still supporting climate and health innovators.
Each angel showed a distinctive pattern. Alan Morgan operated in the fintech pre-seed to seed band, illustrated by Ralio’s £1.8m pre-seed round. Timo Boldt appeared as an operator backing early-stage healthtech, visible in Calibre’s £2.4m raise. Both the Ralio and Calibre figures represent the full round sizes rather than individual cheques. Paul Forster featured in the growth finance automation bracket with Round’s £4.5m round. Matt Clifford took part in larger industrial greentech plays exemplified by Rivan’s £25m growth round, and Sir Ronald Cohen participated at scale in sizeable growth financings shown by MillTech’s $60m round, signalling his continued role in later-stage, strategic deals.
Public figures such as Clifford and Cohen tended to attach to larger, strategic growth rounds that signal endorsement and help unlock institutional capital. Operator angels like Boldt focused on earlier stages where hands-on scaling advice is most valuable. Fintech specialists including Morgan and Forster clustered around payments, treasury and automation, joining rounds that sit between the pre-seed and growth bands and help bridge the gap to venture capital. These angel patterns complement seed and VC activity by de-risking nascent product-market fits and validating sector plays. For founders the practical takeaway is straightforward: finance-adjacent propositions are attracting the most active angel attention this month, and both operator and high-profile angels can provide the credibility and operational support needed to scale.
Venture capital firms: seed-to-mid-market cheques across deep tech, fintech and AI-enabled edtech
| Venture Capital Firms | April Investments | Investment Sector | Location | Funding Round | Contact Details |
|---|---|---|---|---|---|
 Blackfinch Ventures(more info 🔒) Blackfinch Group is a dynamic investment group focused on creating a positi... | Quantcore (£2,500,000, Quantum) Archangel Lightworks (£10,000,000, Space) Third Space Learning (£4,400,000, Edtech) | Gloucester | |||
 Love Ventures(more info 🔒) Love Ventures is an early-stage venture capital firm focused on empowering ... | WholeSum (£980,000, Data) Round (£4,500,000, Fintech) Ralio (£1,800,000, Fintech) | London | |||
Serve First (£5,000,000, Data) Alesi Surgical (£7,000,000, Healthtech) StudentCrowd ($9,000,000, Edtech) | Manchester | ||||
 YFM Equity Partners(more info 🔒) YFM Equity Partners specialises in providing flexible equity solutions to a... | inploi (£3,000,000, Healthtech) Swanky (£7,600,000, Ecommerce) StudentCrowd ($9,000,000, Edtech) | London | |||
Qoro (£560,000, Quantum) Gizmo ($22,000,000, Edtech) | London |
Blackfinch Ventures, Love Ventures, Mercia, YFM Equity Partners and Ada Ventures were the most active VCs in April, collectively driving activity across deep tech, fintech, edtech, healthtech and ecommerce. Quantum and space plays such as Quantcore and Archangel Lightworks sat alongside fintech infrastructure and payments bets including Ralio and Round. AI-enabled learning and data platforms, exemplified by Gizmo, Third Space Learning and WholeSum, also registered strongly. The month highlighted specialist models too, from regional and fund-of-fund structures via Mercia and Midlands Engine allocations to mission-led seed activity at Ada and alternative investor involvement on strategic deals.
Each firm displayed a distinct pattern. Blackfinch operated across seed to growth with a pronounced deep-tech tilt, participating in a seed-to-series deal such as Quantcore (£2.5m, a sub-£3m band) and backing larger technology scale-ups including Archangel Lightworks (£10m) and Third Space Learning (£4.4m), the latter in the £3m–£15m band. Love Ventures concentrated on fintech and data, spanning pre-seed to growth with pre-seed WholeSum (£980k, c. £0.5m–£2m) and Ralio (£1.8m) up to mid-market Round (£4.5m). Mercia and YFM acted as regional and growth-stage anchors, deploying multi-million-pound capital into customer experience and healthtech winners such as Serve First (£5m), Alesi Surgical (£7m) and Swanky (£7.6m). Ada Ventures backed pre-seed quantum middleware Qoro (£560k, c. £200k–£800k) and participated in larger, double-digit million series for fast-scaling edtech.
The flow of capital suggested a clear division of labour across the ecosystem. Mission-led and specialist seed investors de-risk nascent technologies. Early-stage funds and sector-focused VCs convert research into commercial products. Regional or growth houses supply the multi-million-pound rounds that drive scale and international expansion. Strategic motives were evident, with corporate and corporate-adjacent investors targeting industry adjacency, R&D alignment, regulatory or clinical focus and infrastructure-scale commitments. Venture studios and alternative corporate investors played a complementary role in shaping markets and validating business models, creating an integrated pipeline from early innovation through mid-market commercialisation to larger growth capital.
Corporate venture capital: strategic cheques in battery supply chains and greentech deployment
| Corporate Venture Capital Firms | April Investments | Investment Sector | Location | Funding Round | Contact Details |
|---|---|---|---|---|---|
Altilium (£18,500,000, Greentech) |
April 2026’s corporate investment picture was narrow but instructive. SQM Lithium Ventures was the standout CVC, directing capital into energy transition and battery supply-chain opportunities concentrated in two clusters: critical materials and downstream battery processing, and the greentech and mobility infrastructure needed to domesticate supply chains. Banks, insurer-linked arms and venture studios were largely absent from the deal flow, leaving an industrial corporate playbook to dominate corporate participation. Collectively the transactions revealed a clear instinct to protect R&D, secure strategic adjacencies and underwrite deployment at scale.
SQM’s activity exemplified an industrial CVC approach. It backed growth and deployment stage companies that plug directly into its operations and sustainability targets. Its April participation in Altilium — a £18.5m growth round to build a commercial EV battery recycling refinery — sits in the mid-stage growth to upper deployment tier, signalling a preference for ventures that can quickly deliver feedstock and industrial capacity. That cheque placement stresses strategic returns over speculative early science, prioritising downstream processing and material reclamation. These investments also act as R&D complements, providing operational insight while accelerating commercial roll-out.
Across the broader landscape different corporate arms occupy distinct roles. Pharma CVCs calibrate to early science and then shepherd winners through mid-stage clinical programmes, while industrial corporates tilt toward scale-up capital to shore up manufacturing and feedstock security. Banks and insurer-linked units generally operate in a support and debt tier, supplying structured finance for later expansion, and venture studios concentrate on very early validation, spinouts and the formation of new ventures. The layers interact productively: scientific discoveries feed clinical and industrial pipelines, industrial AI speeds operational integration, and structured finance smooths commercialisation. Together these elements form a multi-tiered corporate innovation ecosystem in the UK and Europe that de-risks commercial scale and aligns capital with industrial strategy.
April's activity clarified a division of labour. Angels concentrated expertise and early validation, particularly in fintech and selectively in greentech and healthtech. VCs supplied a continuous seed-to-growth pipeline across deep tech, edtech and fintech. Corporate capital targeted deployment-stage, industrially strategic bets that secure supply chains and operational scale. Angels proved pivotal for product-market de-risking and early credibility, VCs converted validated propositions into commercial traction and mid-market scale, and corporates underwrote the capital-intensive steps that bring technologies into production. The month also reinforced predictable cheque-band behaviour, with angel tickets skewing smaller and provenance-driven, VCs spanning pre-seed through multi-million growth rounds, and CVCs favouring larger, strategic deployments. For founders the takeaway is clear: align your ask and narrative to investor motives, mobilise operator and high-profile angels to validate and open doors, engage sector- and stage-appropriate VCs to commercialise and scale, and approach corporates when your roadmap requires industrial integration or deployment capital.
Click here for a full list of 7,589+ startup investors in the UK